Are you ready for the grand finale of our Year in Review Recording?
The final episode of 2022 is here, and it's one for the books! We've explored the cutting-edge innovations and technologies shaping the future of the biotech industry with some of the most brilliant minds in the field. From Kurt Höller of EIT Health, to Albert Missbichler from Fianostics, Caroline Heil from the new meat company, Mauricio Agudelo and Lina Toro from Bialtec, Kimberly Cornfield from the UCL, Collin Ewald from ETH Zurich, and Guido Gualdoni from G.ST Antiviral, we've had some truly enlightening conversations.
But we saved the best for last!
Get ready for an exclusive interview with Dr. Thomas Schubert, CEO of 2bind, a provider of biophysical outsourcing solutions that is revolutionizing the way we study molecular interactions and protein stability. Don't miss out on this one-of-a-kind episode.
Tune in now!
This cutting-edge biotech company is revolutionizing how we study molecular interactions and protein stability. They're doing it with a track record of over 1400 successfully completed tasks in research projects with over 350 customers in the last 11 years.
In this episode, you'll get an inside look at the driving force behind 2bind and the expert knowledge that sets them apart in the biophysics field. From breakthrough moments to industry trends, you'll gain a deeper understanding of the future of biotech and the role that companies like 2bind will play in shaping it.
But that's not all! You'll also hear from Dr. Schubert about the company's partnerships with leading device producers and how they navigate the digital world to stay ahead of the curve. Plus, you'll get insight into the supply chain challenges that 2bind faced in the last years and how they overcame them.
Don't miss out on this opportunity to learn from the best in the business! Tune in to our latest podcast episode and join the conversation on the future of biotech.
Trust us; this episode is a must-listen for anyone in the biotech industry or anyone passionate about innovation and the future of medicine. It's packed with valuable insights and information you won't miss.
💡 LINKS TO MORE CONTENT.
If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribe
Podcast Episodes: https://pod.link/1493847125
Check out our partners: https://linktr.ee/lsg2
Watch on Youtube
(02:00) Unveiling the mastermind behind 2bind, Dr. Thomas Schubert
(04:05) Insider tips for starting your own biotech company
(07:36) A glimpse into the future: 2022 for 2bind's CEO
(10:40) Navigating the digital world: Pros and cons of technology in biotech
(14:16) Overcoming obstacles: A look at 2bind's supply chain challenges
(18:21) Game-changing developments in biophysics for 2022
(19:53) What's next for the industry? A preview of biophysics trends to come
(23:19) Peeking into the crystal ball: 2bind's plans for 2023
(24:25) Mark your calendars: Upcoming conferences featuring 2bind in 2023
(30:49) Bold predictions for the biotech industry in 2023
(32:33) Addressing the challenges: How to improve drug discovery and development in 2023.
Do you want to support the podcast team?
Join the LSG2G Newsletter as a paying member: Link